Therapy-Related Myeloid Neoplasms

Posted on 2014-01-04
Guest Editor: Richard Larson

 

Table of Contents

 

Perspectives

 

SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML Francesco D'Alò, Luana Fianchi, Emiliano Fabiani, Marianna Criscuolo, Mariangela Greco, Francesco Guidi, Livio Pagano, Giuseppe Leone, Maria Teresa Voso | DOI: 10.4084/mjhid.2011.4

e2011052

  Review Articles

 

GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS Angela Stoddart, Megan E. McNerney, Elizabeth Bartom, Rachel Bergerson, David J. Young, Zhijian Qian, Jianghong Wang, Anthony A. Fernald, Elizabeth M. Davis, Richard A. Larson, Kevin P. White, Michelle M. Le Beau | DOI: 10.4084/mjhid.2011.019

e2011019

EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES Kjeld Schmiegelow | DOI: 10.4084/mjhid.2011.020

e2011020

PROGNOSIS AND THERAPY WHEN ACUTE PROMYELOCYTIC LEUKEMIA AND OTHER “GOOD RISK” ACUTE MYELOID LEUKEMIAS OCCUR AS A THERAPY-RELATED MYELOID NEOPLASM Richard A. Larson, Michelle Le Beau | DOI: 10.4084/mjhid.2011.032

e2011032

THERAPY-RELATED MYELOID NEOPLASMS IN PATIENTS TREATED FOR HODGKIN LYMPHOMA Dennis A Eichenauer, Andreas Engert | DOI: 10.4084/mjhid.2011.046

e2011046

THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS Alessia Bari, Luigi Marcheselli, Raffaella Marcheselli, Eliana Valentina Liardo, Samantha Pozzi, Stefano Sacchi | DOI: 10.4084/mjhid.2011.065

e2011065

INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER Caterina Giovanna Valentini, Luana Fianchi, Maria Teresa Voso, Morena Caira, Giuseppe Leone, Livio Pagano | DOI: 10.4084/mjhid.2011.069

e2011069

THERAPY-RELATED MYELOID NEOPLASMS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND WALDENSTROM MICROGLOBULINEMIA Francesca Ricci, Alessandra Tedeschi, Marco Montillo, Enrica Morra | DOI: 10.4084/mjhid.2011.031

e2011031

THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA Xenofon Papanikolaou, Bart Barlogie, Saad Usmani | DOI: 10.4084/mjhid.2011.047

e2011047

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY Ercole Brusamolino, Manuel Gotti, Valeria Fiaccadori | DOI: 10.4084/mjhid.2012.022

e2012022

MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA Melanie Joannides, Ashley N Mays, Anita R Mistry, Syed Khizer Hasan, Andreas Reiter, Joseph L Wiemels, Carolyn A Felix, Francesco Lo-Coco, Neil Osheroff, Ellen Solomon, David Grimwade | DOI: 10.4084/mjhid.2011.045

e2011045